| Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort P Vizcarra, MJ Pérez-Elías, C Quereda, A Moreno, MJ Vivancos, ... The lancet HIV 7 (8), e554-e564, 2020 | 415 | 2020 |
| Fecal microbiota transplantation in HIV: A pilot placebo-controlled study S Serrano-Villar, A Talavera-Rodríguez, MJ Gosalbes, N Madrid, ... Nature Communications 12 (1), 1139, 2021 | 64 | 2021 |
| Human immunodeficiency virus/hepatitis C virus coinfection in Spain: prevalence and patient characteristics J Berenguer, A Rivero, I Jarrín, MJ Núñez, MJ Vivancos, M Crespo, ... Open forum infectious diseases 3 (2), ofw059, 2016 | 60 | 2016 |
| Monkeypox virus case with maculopapular exanthem and proctitis during the Spanish outbreak in 2022. B de Nicolas‐Ruanes, MJ Vivancos, C Azcarraga‐Llobet, AM Moreno, ... Journal of the European Academy of Dermatology & Venereology 36 (8), 2022 | 51 | 2022 |
| Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study S Serrano-Villar, J Martínez-Sanz, R Ron, A Talavera-Rodríguez, ... The lancet HIV 7 (8), e565-e573, 2020 | 48 | 2020 |
| COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study C Díez, J Del Romero‐Raposo, R Mican, JC López, JR Blanco, ... HIV medicine 22 (9), 867-876, 2021 | 33 | 2021 |
| Human immunodeficiency virus/hepatits C virus coinfection in Spain: elimination is feasible, but the burden of residual cirrhosis will be significant J Berenguer, I Jarrín, L Pérez-Latorre, V Hontañón, MJ Vivancos, ... Open forum infectious diseases 5 (1), ofx258, 2018 | 31 | 2018 |
| Impact of a structured HIV testing program in a hospital emergency department and a primary care center C Gómez-Ayerbe, J Martínez-Sanz, A Muriel, P Pérez Elías, A Moreno, ... PLoS One 14 (8), e0220375, 2019 | 28 | 2019 |
| Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals AYM Howe, C Rodrigo, EB Cunningham, MW Douglas, J Dietz, J Grebely, ... JHEP Reports 4 (5), 100462, 2022 | 26 | 2022 |
| Management of comorbidities in treated HIV infection: a long way to go: HIV, comorbidities and aging J Martínez-Sanz, S Serrano-Villar, MJ Vivancos, R Rubio, S Moreno, ... International Journal of Antimicrobial Agents 59 (1), 106493, 2022 | 26 | 2022 |
| Efficacy and safety of dolutegravir plus boosted-darunavir dual therapy among highly treatment-experienced patients P Vizcarra, M Fontecha, M Monsalvo, MJ Vivancos, A Rojo, JL Casado Antiviral Therapy 24 (6), 467-471, 2019 | 23 | 2019 |
| Case Report: Sequential Chikungunya and Zika Virus Infections in a Traveler from Honduras FF Norman, S Chamorro, A Vázquez, MP Sánchez-Seco, ... The American journal of tropical medicine and hygiene 95 (5), 1166, 2016 | 22 | 2016 |
| Human monkeypox in people with HIV: transmission, clinical features, and outcome MJ Vivancos-Gallego, M Sánchez-Conde, M Rodríguez-Domínguez, ... Open Forum Infectious Diseases 9 (11), ofac557, 2022 | 20 | 2022 |
| Risk of cancer in HIV-infected patients in Spain, 2004–2015. The CoRIS cohort study J García-Abellán, L Del Río, JA García, S Padilla, MJ Vivancos, ... Enfermedades infecciosas y microbiologia clinica (English ed.) 37 (8), 502-508, 2019 | 20 | 2019 |
| Outcome of an HIV education program for primary care providers: Screening and late diagnosis rates J Martínez Sanz, MJ Pérez Elías, A Muriel, C Gómez Ayerbe, ... PLoS One 14 (7), e0218380, 2019 | 19 | 2019 |
| Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties MS Conde, MJ Vivancos, SM Guillén Farmacia Hospitalaria 41 (5), 630-637, 2017 | 19 | 2017 |
| Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019 C Fanciulli, J Berenguer, C Busca, MJ Vivancos, MJ Téllez, L Domínguez, ... HIV medicine 23 (7), 705-716, 2022 | 18 | 2022 |
| CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment M Monsalvo, A Vallejo, M Fontecha, MJ Vivancos, P Vizcarra, JL Casado International journal of STD & AIDS 30 (7), 656-662, 2019 | 18 | 2019 |
| Dolutegravir plus rilpivirine in suppressed heavily pretreated HIV-infected patients A Diaz, JL Casado, F Dronda, C Gomez-Ayerbe, MJ Vivancos, S Banon, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 19, 2016 | 18 | 2016 |
| Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020; 7 (8): e554–64 P Vizcarra, MJ Pérez-Elías, C Quereda, A Moreno, MJ Vivancos, ... Epub 2020/06/01. doi: 10.1016/S2352-3018 (20) 30164-8. PubMed PMID: 32473657, 0 | 18 | |
